Chairman of the Board, FlowMetric Diagnostics
Renold has over 20 years of experience in pharmaceutical research and development. He is an expert in polychromatic flow cytometry, cell sorting and immunology-based assay development. Renold is Founder and CEO of FlowMetric Inc., a leader in flow cytometry and cell sorting services.
Prior to establishing FlowMetric, Renold worked for over 13 years at Centocor, a subsidiary of Johnson and Johnson. He established the polychromatic flow facility at Centocor to perform polychromatic flow cytometry and cell sorting. His work at Centocor earned him five prestigious Johnson & Johnson awards for scientific excellence and innovation. He has worked on marketed compounds, Remicade® and Stelara®. Renold has authored more than 30 peer reviewed scientific manuscripts and publications. He is co-author of one US Patent and has been invited to speak at International Conferences. He has also co-authored a chapter on the “Application of Flow Cytometry in Drug Development” for Immunotoxicology Strategies for Pharmaceutical Safety Assessment, published by John Wiley & Sons in August 2008.
Renold earned his undergraduate degree from Villanova University. Renold is also a board member of iPraxis, a not-for-profit educational organization focused on science and technology education, is a member of the Board of Trustees for Neumann University and an Adjunct Professor at Drexel University College of Medicine.